Vor Biopharma Inc. (VOR)
VOR Stock Price Chart
Explore Vor Biopharma Inc. interactive price chart. Choose custom timeframes to analyze VOR price movements and trends.
VOR Company Profile
Discover essential business fundamentals and corporate details for Vor Biopharma Inc. (VOR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Feb 2021
Employees
159.00
Website
https://www.vorbio.comCEO
Robert Ang MBBS
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
VOR Financial Timeline
Browse a chronological timeline of Vor Biopharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.12.
Earnings released on 12 Aug 2025
EPS came in at -$2.18 falling short of the estimated -$0.57 by -282.46%.
Earnings released on 14 May 2025
EPS came in at -$0.26 falling short of the estimated -$0.25 by -4.00%.
Earnings released on 20 Mar 2025
EPS came in at -$0.44 falling short of the estimated -$0.34 by -29.41%.
Earnings released on 7 Nov 2024
EPS came in at -$0.40 matching the estimated -$0.40.
Earnings released on 8 Aug 2024
EPS came in at -$0.41 matching the estimated -$0.41.
Earnings released on 9 May 2024
EPS came in at -$0.45 falling short of the estimated -$0.37 by -21.62%.
Earnings released on 20 Mar 2024
EPS came in at -$0.39 surpassing the estimated -$0.49 by +20.41%, while revenue for the quarter reached $12.23M .
Earnings released on 7 Nov 2023
EPS came in at -$0.49 falling short of the estimated -$0.46 by -6.52%.
Earnings released on 10 Aug 2023
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 11 May 2023
EPS came in at -$0.43 falling short of the estimated -$0.38 by -13.16%.
Earnings released on 23 Mar 2023
EPS came in at -$0.53 surpassing the estimated -$0.56 by +5.36%.
Earnings released on 10 Nov 2022
EPS came in at -$0.63 falling short of the estimated -$0.60 by -5.00%.
Earnings released on 11 Aug 2022
EPS came in at -$0.58 surpassing the estimated -$0.67 by +13.43%.
Earnings released on 12 May 2022
EPS came in at -$0.61 falling short of the estimated -$0.54 by -12.96%.
Earnings released on 14 Mar 2022
EPS came in at -$0.49 surpassing the estimated -$0.55 by +10.91%.
Earnings released on 10 Nov 2021
EPS came in at -$0.50 surpassing the estimated -$0.58 by +13.79%.
Earnings released on 9 Aug 2021
EPS came in at -$0.50 falling short of the estimated -$0.47 by -6.38%.
Earnings released on 6 May 2021
EPS came in at -$0.67 surpassing the estimated -$0.83 by +19.28%.
Earnings released on 25 Mar 2021
EPS came in at -$217.49 falling short of the estimated -$4.40 by -4.84K%.
Earnings released on 18 Dec 2020
EPS came in at -$0.66 .
Earnings released on 30 Sept 2020
EPS came in at -$0.97 .
VOR Stock Performance
Access detailed VOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.